MLICM
LOXO

Metropolitan Life Insurance Company (MetLife)’s Loxo Oncology, Inc LOXO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,611
Closed -$1.21M – 2602
2018
Q4 		$1.21M Buy
8,611
+57
+0.7% +$8.65K 0.02% 688
2018
Q3 		$1.46M Hold
8,554
– – 0.02% 704
2018
Q2 		$1.48M Buy
8,554
+1,517
+22% +$228K 0.02% 701
2018
Q1 		$812K Sell
7,037
-274
-4% -$29.1K 0.01% 997
2017
Q4 		$615K Sell
7,311
-8,071
-52% -$673K 0.01% 1146
2017
Q3 		$1.42M Buy
15,382
+1,726
+13% +$134K 0.01% 1071
2017
Q2 		$1.09M Buy
13,656
+3,097
+29% +$172K 0.01% 1191
2017
Q1 		$444K Hold
10,559
– – ﹤0.01% 1736
2016
Q4 		$339K Sell
10,559
-3,863
-27% -$99K ﹤0.01% 2014
2016
Q3 		$378K Buy
14,422
+3,863
+37% +$101K ﹤0.01% 1894
2016
Q2 		$245K Buy
10,559
+3,588
+51% +$89.3K ﹤0.01% 2190
2016
Q1 		$191K Hold
6,971
– – ﹤0.01% 2207
2015
Q4 		$198K Buy
+6,971
New +$187K ﹤0.01% 2278

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LOXO Position: Q1 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 8,611 shares — an estimated $1.21M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $1.48M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,611 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.21M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Loxo Oncology, Inc position peaked at $1.48M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2019, filed 15 May 2019.